Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association

Barbara S. Wiggins; Joseph J. Saseen; Robert L. Page; Brent N. Reed; Kevin Sneed; John B. Kostis; David Lanfear; Salim Virani; Pamela B. Morris

doi:10.1161/CIR.0000000000000456

Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association

Barbara S. Wiggins, Joseph J. Saseen, Robert L. Page, Brent N. Reed, Kevin Sneed, John B. Kostis, David Lanfear, Salim Virani, Pamela B. Morris

Office of the Provost

Research output: Contribution to journal › Article › peer-review

289 Citations (Scopus)

Original language	English (UK)
Pages (from-to)	e468-e495
Journal	Circulation
Volume	134
Issue number	21
DOIs	https://doi.org/10.1161/CIR.0000000000000456
Publication status	Published - 22 Nov 2016

Keywords

AHA Scientific Statements
anti-arrhythmic agents
anticoagulants
calcium channel blockers
cardiovascular disease
drug-related side effects and adverse reactions
fenofibrate/fenofibric acid derivatives
gemfibrozil
hydroxymethylglutaryl-CoA reductase inhibitors
immunosuppressive agents

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/CIR.0000000000000456

Cite this

Wiggins, B. S., Saseen, J. J., Page, R. L., Reed, B. N., Sneed, K., Kostis, J. B., Lanfear, D., Virani, S., & Morris, P. B. (2016). Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation, 134(21), e468-e495. https://doi.org/10.1161/CIR.0000000000000456

@article{e0061eded86b4337aee16cb0cef51c63,

title = "Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association",

keywords = "AHA Scientific Statements, anti-arrhythmic agents, anticoagulants, calcium channel blockers, cardiovascular disease, drug-related side effects and adverse reactions, fenofibrate/fenofibric acid derivatives, gemfibrozil, hydroxymethylglutaryl-CoA reductase inhibitors, immunosuppressive agents",

author = "Wiggins, \{Barbara S.\} and Saseen, \{Joseph J.\} and Page, \{Robert L.\} and Reed, \{Brent N.\} and Kevin Sneed and Kostis, \{John B.\} and David Lanfear and Salim Virani and Morris, \{Pamela B.\}",

year = "2016",

month = nov,

day = "22",

doi = "10.1161/CIR.0000000000000456",

language = "English (UK)",

volume = "134",

pages = "e468--e495",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "21",

}

Wiggins, BS, Saseen, JJ, Page, RL, Reed, BN, Sneed, K, Kostis, JB, Lanfear, D, Virani, S & Morris, PB 2016, 'Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association', Circulation, vol. 134, no. 21, pp. e468-e495. https://doi.org/10.1161/CIR.0000000000000456

Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association. / Wiggins, Barbara S.; Saseen, Joseph J.; Page, Robert L. et al.
In: Circulation, Vol. 134, No. 21, 22.11.2016, p. e468-e495.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease

T2 - A Scientific Statement from the American Heart Association

AU - Wiggins, Barbara S.

AU - Saseen, Joseph J.

AU - Page, Robert L.

AU - Reed, Brent N.

AU - Sneed, Kevin

AU - Kostis, John B.

AU - Lanfear, David

AU - Virani, Salim

AU - Morris, Pamela B.

PY - 2016/11/22

Y1 - 2016/11/22

KW - AHA Scientific Statements

KW - anti-arrhythmic agents

KW - anticoagulants

KW - calcium channel blockers

KW - cardiovascular disease

KW - drug-related side effects and adverse reactions

KW - fenofibrate/fenofibric acid derivatives

KW - gemfibrozil

KW - hydroxymethylglutaryl-CoA reductase inhibitors

KW - immunosuppressive agents

UR - https://www.scopus.com/pages/publications/84991502977

U2 - 10.1161/CIR.0000000000000456

DO - 10.1161/CIR.0000000000000456

M3 - Article

C2 - 27754879

AN - SCOPUS:84991502977

SN - 0009-7322

VL - 134

SP - e468-e495

JO - Circulation

JF - Circulation

IS - 21

ER -

Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association

Keywords

UN SDGs

Access to Document

Other files and links

Cite this